These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
675 related articles for article (PubMed ID: 22613005)
1. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005 [TBL] [Abstract][Full Text] [Related]
2. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma. Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of miR-497 promotes tumor growth and angiogenesis by targeting HDGF in non-small cell lung cancer. Zhao WY; Wang Y; An ZJ; Shi CG; Zhu GA; Wang B; Lu MY; Pan CK; Chen P Biochem Biophys Res Commun; 2013 Jun; 435(3):466-71. PubMed ID: 23673296 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. He XX; Chang Y; Meng FY; Wang MY; Xie QH; Tang F; Li PY; Song YH; Lin JS Oncogene; 2012 Jul; 31(28):3357-69. PubMed ID: 22056881 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365 [TBL] [Abstract][Full Text] [Related]
6. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of TGF-β/SMAD3/NF-κB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Jiang F; Wang X; Liu Q; Shen J; Li Z; Li Y; Zhang J Toxicol Lett; 2014 Nov; 231(1):55-61. PubMed ID: 25196641 [TBL] [Abstract][Full Text] [Related]
9. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. Wang C; Song B; Song W; Liu J; Sun A; Wu D; Yu H; Lian J; Chen L; Han J J Gastroenterol Hepatol; 2011 Nov; 26(11):1630-7. PubMed ID: 21557766 [TBL] [Abstract][Full Text] [Related]
10. MiR-146a enhances angiogenic activity of endothelial cells in hepatocellular carcinoma by promoting PDGFRA expression. Zhu K; Pan Q; Zhang X; Kong LQ; Fan J; Dai Z; Wang L; Yang XR; Hu J; Wan JL; Zhao YM; Tao ZH; Chai ZT; Zeng HY; Tang ZY; Sun HC; Zhou J Carcinogenesis; 2013 Sep; 34(9):2071-9. PubMed ID: 23671131 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-195 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting the expression of VEGF, VAV2, and CDC42. Wang R; Zhao N; Li S; Fang JH; Chen MX; Yang J; Jia WH; Yuan Y; Zhuang SM Hepatology; 2013 Aug; 58(2):642-53. PubMed ID: 23468064 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of HDGF Inhibits the Growth of Hepatocellular Carcinoma Cells In Vitro and In Vivo. Enomoto H; Nakamura H; Liu W; Iwata Y; Nishikawa H; Takata R; Yoh K; Hasegawa K; Ishii A; Takashima T; Sakai Y; Aizawa N; Ikeda N; Iijima H; Nishiguchi S Anticancer Res; 2015 Dec; 35(12):6475-9. PubMed ID: 26637859 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302 [TBL] [Abstract][Full Text] [Related]
14. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma. Law PT; Ching AK; Chan AW; Wong QW; Wong CK; To KF; Wong N Carcinogenesis; 2012 Jun; 33(6):1134-41. PubMed ID: 22431718 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma. Zhang T; Liu W; Zeng XC; Jiang N; Fu BS; Guo Y; Yi HM; Li H; Zhang Q; Chen WJ; Chen GH Biomed Pharmacother; 2016 Dec; 84():583-591. PubMed ID: 27694002 [TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma. Xie Q; Chen X; Lu F; Zhang T; Hao M; Wang Y; Zhao J; McCrae MA; Zhuang H Cancer; 2012 May; 118(9):2431-42. PubMed ID: 21989846 [TBL] [Abstract][Full Text] [Related]
17. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145. Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186 [TBL] [Abstract][Full Text] [Related]
18. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Liu X; Zhang A; Xiang J; Lv Y; Zhang X Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244 [TBL] [Abstract][Full Text] [Related]
19. Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma. Diao S; Zhang JF; Wang H; He ML; Lin MC; Chen Y; Kung HF Proteomics; 2010 Oct; 10(20):3723-31. PubMed ID: 20859956 [TBL] [Abstract][Full Text] [Related]
20. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]